Acute lymphoblastic leukemia (ALL) is a type of cancer of the blood and bone marrow that affects the white blood cells. It is the most common type of childhood cancer. The prognosis for ALL depends on several factors, including age, risk factors, and response to treatment.
Overview of Acute Lymphoblastic Leukemia
ALL is a cancer of the white blood cells. It develops when the bone marrow starts to produce abnormal white blood cells. This can cause a decrease in the production of healthy white blood cells, red blood cells, and platelets. Symptoms of ALL include fatigue, fever, bruising, and an increased risk of infection.
Risk Factors for Acute Lymphoblastic Leukemia
Certain factors may increase the risk of developing ALL. These include exposure to radiation or certain chemicals, having a weakened immune system, and certain genetic conditions.
Diagnosing Acute Lymphoblastic Leukemia
ALL is diagnosed through a number of tests, including blood tests, bone marrow aspiration, and a physical exam.
Treating Acute Lymphoblastic Leukemia
Treatment for ALL usually involves a combination of chemotherapy, radiation, and stem cell transplant. The goal of treatment is to induce remission and prevent relapse.
Chances of Surviving Acute Lymphoblastic Leukemia
The prognosis for ALL depends on several factors, including age, risk factors, and response to treatment. Overall, the 5-year survival rate for ALL is about 85%. However, this varies depending on age and other factors.